Summary for Patients: Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV

被引：0
|
作者：
不详
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 06期
关键词：
D O I：
10.7326/P21-0002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I21 / I21
页数：1
相关论文
共 50 条
  • [1] Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV A Cohort Study
    Surial, Bernard
    Mugglin, Catrina
    Calmy, Alexandra
    Cavassini, Matthias
    Gunthard, Huldrych F.
    Stockle, Marcel
    Bernasconi, Enos
    Schmid, Patrick
    Tarr, Philip E.
    Furrer, Hansjakob
    Ledergerber, Bruno
    Wandeler, Gilles
    Rauch, Andri
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : 758 - +
  • [2] Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
    Laurence Brunet
    Patrick Mallon
    Jennifer S. Fusco
    Michael B. Wohlfeiler
    Girish Prajapati
    Andrew Beyer
    Gregory P. Fusco
    [J]. Clinical Drug Investigation, 2021, 41 : 955 - 965
  • [3] Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
    Brunet, Laurence
    Mallon, Patrick
    Fusco, Jennifer S.
    Wohlfeiler, Michael B.
    Prajapati, Girish
    Beyer, Andrew
    Fusco, Gregory P.
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (11) : 955 - 965
  • [4] Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide
    Schafer, Jason J.
    Zimmerman, Matty
    Walshe, Ciara
    Cerankowski, Jesse
    Shimada, Ayako
    Keith, Scott W.
    [J]. OBESITY, 2022, 30 (06) : 1197 - 1204
  • [5] Impact of COVID-19 pandemic and switching from tenofovir disoproxil fumarate to tenofovir alafenamide on weight gain in people living with HIV
    Milinkovic, A.
    Goyal, K.
    Pereira, B.
    Soler-Carracedo, A.
    Hickey, W.
    Mazzitelli, M.
    Moyle, G.
    Boffito, M.
    [J]. HIV MEDICINE, 2021, 22 : 175 - 176
  • [6] Young age is a key determinant of body weight gain after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in Japanese people living with HIV
    Sekiya, Ryoko
    Muramatsu, Takashi
    Ichiki, Akito
    Chikasawa, Yushi
    Bingo, Masato
    Yotsumoto, Mihoko
    Hagiwara, Takeshi
    Amano, Kagehiro
    Kinai, Ei
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (02) : 171 - 178
  • [7] Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV
    Gilbert, Jared M. M.
    Vest, Kirsten
    Kish, Troy D. D.
    [J]. PHARMACY, 2022, 10 (06)
  • [8] Switching from Tenofovir Disoproxil to Tenofovir Alafenamide Fumarate: Impact on Cardiovascular Risk and Lipid Profile in People Living with HIV, an Observational Study
    Moschopoulos, Charalampos D.
    Protopapas, Konstantinos
    Thomas, Konstantinos
    Kavatha, Dimitra
    Papadopoulos, Antonios
    Antoniadou, Anastasia
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2023, 39 (02) : 68 - 75
  • [9] Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults living with HIV: a multicentre prospective cohort study
    Martinez-Sanz, J.
    Serrano-Villar, S.
    Muriel, A.
    Garcia Fraile, L.
    Orviz, E.
    Mena de Cea, A.
    Campins, A.
    Moreno Guillen, S.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 140 - 141
  • [10] Safety and efficacy of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV aged 50 years and older
    Stellbrink, H-J
    Post, F. A.
    Podzamczer, D.
    Arribas, J.
    Cua, E.
    Molina, J-M
    Orkin, C.
    Rockstroh, J. K.
    Carter, C.
    Liu, Y-P
    Zhong, L.
    Das, M.
    Temme, L.
    Waters, L.
    [J]. HIV MEDICINE, 2019, 20 : 138 - 138
12345